Intelligence · Patent portfolio
ALMIRALL S.P.A Patents
Full USPTO pharma patent portfolio for ALMIRALL S.P.A — grant dates, expiration, and drug cross-links.
- Patents
- 308
- Expiring ≤24m
- 14
Quick answer
ALMIRALL S.P.A has 308 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 14 expire within 24 months — use filters for patent-cliff planning.
-
US 6906050
Substituted porphyrin and azaporphyrin derivatives and their use in photodynamic therapy, radioimaging and MRI diagnosis
expired -
US 6887862
Method for improving treatment selectivity and efficacy using intravascular photodynamic therapy
expired -
US 6869968
2-(3H)-oxazolone derivatives and their use as COX-2 inhibitors
expired -
US 6827926
Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy
expired -
US 6794505
Chlorins possessing fused ring systems useful as photoselective compounds for photodynamic therapy
expired -
US 6750226
Quinuclidine derivatives and their use as muscarinic M3 receptor ligands
expired -
US 6683096
Indolylpiperidine derivatives as antihistaminic and antiallergic agents
expired -
US 6605606
Solid forms of tin ethyl etiopurpurin and processes for producing such forms
expired -
US 6600012
Lipid-modified muc-1 derivatives
expired -
US 6582697
Enhancement of the cellular immune response
expired -
US 6544549
Multilamellar coalescence vesicles (MLCV) containing biologically active compounds
expired -
US 6518303
2-phenylpyran-4-one derivatives
expired -
US 6462192
Processes for large scale production of tetrapyrroles
expired -
US 6444194
Indium photosensitizers for PDT
expired -
US 6407108
1,2,4-triazolo(4,3-b)pyrido(3,2-d)pyridazine derivatives and pharmaceutical compositions containing them
expired -
US 6376483
Bacteriochlorins and bacteriopurpurins useful as photoselective compounds for photodynamic therapy and a process for their production
expired -
US 6326009
Enhancement of the cellular immune response
expired -
US 6312718
Vaccine for B-cell malignancies
expired -
US 6207170
Patient-specific white blood cell malignancy vaccine from membrane-proteoliposomes
expired -
US 6054449
Compounds and method for PDT of intimal hyperplasia and other diseases
expired
Frequently asked questions
How many patents does ALMIRALL S.P.A have?
308 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do ALMIRALL S.P.A patents expire?
14 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.
Where does this data come from?
USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.
Data attribution: Data sources · Patent directory